sufficient stability to give a good result. The stabilized gliding knee replacement (Fig 2) is a compromise between these two. It is a two-piece implant, the femoral being of chrome cobalt alloy and the tibial of high density polyethylene. The two components are linked by a stabilizing rod which can rotate within the femoral prosthesis. The design is such that both rotation and lateral movements are well controlled in extension but there is a built-in laxity of both which increases as the knee is flexed. In addition the joint surfaces are shaped so that the joint opens in each of these mdvements, tightening the soft tissues and taking some of the strain from the cement/bone interface.
At Hastings 104 of these knee replacements have been done and a good many more in various parts of Great Britain, Europe and America. The operation has only been in use for three-and-a-half years but the first 107 knees have been reviewed. In over 50 the follow-up time was more than a year. Range ofmovement: In this series 65 % of patients had more than 900 flexion before operation and 15 % less than 600 of movement. After operation 70 % had a range of flexion of more than 900 and less than 5% of under 600. Nearly 30% of the patients had a flexion deformity of more than 150 before operation but none had this severity of deformity afterwards. More than 70% had less than 50 after operation. Walking ability: This was classified as good if the patient could walk an unlimited distance using only one stick. Before operation less than I % fell into this category. After operation nearly 80% were classified as 'good'. Pain relief: Patients were classified as a good result if they had no pain at all or a slight ache at times. Before operation there were no patients in this category; all of them had severe and spontaneous pain or severe pain on walking. After operation 98 % of the patients were classified as a good result with no pain or a slight ache at times and 59 % denied having any pain at all.
The title of this symposium, 'Locomotor Disability in the Elderly -Disease or Decay ?', implies a question that requires an answer. A surgeon cannot provide this answer. The dividing line between disease and decay can be very indistinct indeed. A condition such as osteoarthritis has for many years been considered to be a disease but it is now widely recognized as often a simple wear and tear and, therefore, presumably decay. Some subcapital fractures of the neck of the femur have always been considered as indications of decay but in some parts' of the country it is almost an endemic disease which sometimes achieves epidemic proportions. No- where is this more apparent than on parts of the south coast, now often known as the 'Costa Geriatrica'. The Management of Osteoporosis Loss of bone mineral from the skeleton is a universal phenomenon of ageing (Garn et al. 1967 , Exton-Smith et al. 1969 , Gryfe et al. 1971 . A slow rate of loss begins after the age of 40 in both sexes, but it becomes accelerated in women after the menopause. In addition to this physiological bone loss, osteoporosis due to excessive loss of bone mineral occurs in a number of unrelated conditions such as corticosteroid excess, rheumatoid arthritis and following partial gastrectomy.
In clinical practice the bone loss is often not detected until structural failure of the skeleton occurs. This is usually manifest by fracture of the ends of the long bones (particularly of the wrist, the femoral neck and the upper end of the humerus) or by collapse of the vertebral bodies in the lumbar and thoracic regions. Knowelden et al. (1964) have examined the fracture patterns occurring after the age of 35 and two fractures showing a remarkable change in incidence with age must be mentioned:
(1) Colles fracture: In women at the age of 60 the incidence is ten times that occurring at the age of 40. In men there is only a slow increase with age from 35 onwards and, in particular, there is no striking increase between 40 and 60 as in women.
(2) Femoral neck fracture: In both sexes the rates are small below the age of 60, but after this they increase exponentially with age, doubling every 5 years in women and every 8 years in men. Nordin (1966) has investigated the incidence of crush fractures of the vertebral bodies. After the age of 45 there is a progressive increase and in women by the age of 75 nearly 50% of spinal X-rays show vertebral fractures.
Bone mineral content and loss have been measured in several ways: (I) By radiographic morphometry by measurement of cortical width in long bones, particularly metacarpals, from which indices have been derived (Nordin & Smith 1965 , Exton-Smith et al. 1969 , Garn 1970 ).
(2) By radiodensitometry by comparison with graded standards (Doyle 1972 , Meema et al. 1964 . (3) By photon absorptiometry by determination of the degree of absorption of low energy y-rays by bone (Cameron & Sorenson 1963 , Wilson 1973 ). These methods have generally been applied to the measurement of the mineral content of cortical bone. Although it has been shown that vertebral density is linearly related to metacarpal cortical thickness (Smith & Rizek 1966) , the mineral content of the bones of the appendicular skeleton is more closely correlated. Methods of measuring mineral content of trabecular bone are not altogether satisfactory, yet it is those sites containing a higher proportion of trabecular bone which are most likely to fracture.
Problems in Management
Several problems face the clinician in the management of osteoporosis: Prolonged duration of the process: When the duration of the operative factors is prolonged over a period of twenty years or more, it is inevitable that the disease becomes more frequent with advancing age. In consequence the process will appear as a manifestation of ageing and our problem is to determine whether the changes we observe in the skeleton are due to ageing alone or whether they can be influenced by nutritional, hormonal and other factors. Furthermore agerelated changes occur in many metabolic processes (e.g. calcium absorption declines with age, and these will correlate with bone mineral loss and because of this it may be assumed that a causal relationship exists between them. Assessment ofskeletal status at maturity: Newton-John & Morgan (1968) postulate that osteoporosis is the result of bone loss which accompanies ageing in individuals with skeletons having a low mineral content at maturity, i.e. it is the result of senescence rather than a disease process. They have shown from a model of bone loss in women that the incidence of fracture of the femoral neck parallels the frequency with which the amount of bone in the metacarpal falls below a critical level of 2.5 s.d. below the mean amount of bone at the age of 30. Apart from the impossibility of determining what was the skeletal status at maturity such a hypothesis would lead to a nihilistic approach to the therapy of osteoporosis since the likelihood of development of osteoporosis and sustaining a fracture in old age is considered to be related to skeletal development in childhood.
The results of a study of 384 cases of fracture of the femoral neck (Exton-Smith 1976) fail to support this hypothesis. The individual values of the metacarpal cortical ratio for the fracture cases have been plotted on the percentile ranking curves for the general population and these are shown in Figs 1 & 2. There is a wide scatter of values and many of these are in the higher percentile ranges. Individuals with denser bones originally may still have weaker bones in comparison with the former strength at maturity, yet they may not appear to be osteoporotic on radiographic examination. It is our aim to make a diagnosis of osteoporosis before skeletal failure (fracture) occurs, but this would be difficult in these cases. Prospective studies are required to ascertain whether those who sustain fractures lose bone excessively or whether they represent a selected group in the general population who have an inferior skeletal status in earlier life. Tendencyfor osteoporosis to improve spontaneously: Dent & Watson (1966) have emphasized that osteoporosis has an episodic course; there may be long intervals between the attacks of pain associated with vertebral collapse. No treatment is known to influence the course of the acute attack, but any treatment given may appear to be effective. Thus the evaluation of different forms of treatment is difficult. .1 J.ul A therapy has been difficult to obtain. Davis et al. (1966) and Meema & Meema (1968) have shown that if oestrogens are given soon after the menopause the bone loss which would otherwise occur could be prevented. Aitken et al. (1973) and Lindsay et al. (1976) have assessed the value of mestranol given in an average daily dose of 23 ,tg to oophorectomized women who participated in a double blind trial. The placebo treated women showed a steady loss of bone with age which occurred most rapidly immediately after oophorectomy. Mestranol prevented bone loss when given two months after oophorectomy and caused a significant increase in bone mineral content when started within three years; it failed, however, to prevent bone mineral loss when treatment was delayed until 6 years after operation. These investigations clearly demonstrated the osteotrophic response to oestrogen and emphasized the importance of the time interval between oophorectomy and the start of treatment. , In the follow up study of postmenopausal women, Meema & Meema showed there was a significantly slower rate of bone mineral loss in women who had been treated with oestrogens. But it was also found that in untreated women who had sustained osteoporotic fractures the loss of bone had been no more rapid than in nonosteoporotic subjects. The use of cestrogens might be a means of preventing Colles fracture, of which the incidence shows a striking rise immediately after the menopause. It could be expected that fractures would occur in those women who have shown an excessive loss of bone compared with postmenopausal women of comparable age without fractures. Our studies have shown that this is not the case (Exton-Smith 1976) . Eleven per cent of elderly women who participated in a nutrition survey had sustained a Colles fracture and the mean metacarpal ratio in the fracture cases was almost identical to that found in the general population of similar age without fractures. Nordin et al. (1975a) , using longitudinal studies of metacarpal measurements, failed to reveal any accelerated bone loss in idiopathic Colles fracture cases. Nevertheless, the reduction in bone strength, associated with mineral loss, in comparison with that at maturity is probably the main reason for the increase in Colles fracture rate immediately after the menopause.
The marked rise in incidence of fracture of the femoral neck begins after the age of 60, some twenty years later than the increase in Colles fracture rate in women. The postmenopausal loss of bone cannot alone account for the increased fracture rate and the additional factor is the loss of bone due to ageing or a pathological loss due to other disease. The administration of cestrogens to prevent the postmenopausal bone loss might be expected to reduce the fracture rate later, but their use and the follow up to assess the incidence of fractures would have to be continued over a prolonged period of thirty or more years. Vitamin D: Studies of bone biopsy material from the iliac crest in patients with femoral neck fractures by the Leeds workers (Aaron et al. 1974) have shown that osteomalacia is present in about one-third of cases. They suggest that for every case of proven osteomalacia representing severe vitamin D depletion there must be others with minor degrees of vitamin D deficiency. Furthermore, they consider that, in view of the dominant role played by vitamin D deficiency in calcium absorption, possibly malabsorption of calcium in elderly people may be a manifestation of vitamin D deficiency falling short of that required to produce osteomalacia and this must at least contribute to senile bone loss. The considerable increase in the amount of osteoid in bone biopsy specimens taken from patients with femoral neck fractures has also been reported by Faccini et al. (1976) . They found the mean value for trabecular osteoid area in the fracture group was 4 % compared with 1 % in age-matched controls without fractures. The difference in the measurements of trabecular surfaces covered by osteoid was also striking; 24.5% in the fracture group and 7.9% for the control group.
Metabolic bone disease due to vitamin D deficiency in the elderly has been attributed to a fall in dietary intake of vitamin D (Exton-Smith 1971); a reduction in exposure to sunlight (Stamp & Round 1974) ; an increase in physiological requirements for vitamin D (Dent 1970) ; and impaired conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol (Fraser & Kodicek 1970) due to decline in renal function in old age. In almost every case multiple factors are present and it is unlikely that vitamin D deficiency is of dietary origin alone; this is confirmed in that large doses of vitamin D are often required to treat osteomalacia in the elderly. The Leeds workers have shown that vitamin D given in doses of 10 000 to 20 000 iu per day can increase calcium absorption and possibly reduce the accelerated bone loss in old age (Nordin et al. 1975b) . Fluoride: On the basis of the production of osteosclerosis by fluoride ingestion, Rich et al. (1964) have suggested that fluoride might be a useful agent in the treatment of osteoporosis. Although animal experiments have shown that fluoride administration causes osteoblastic stimulation, the newly formed bone tissue is poorly mineralized resulting in the histological appearance of osteomalacia. Jowsey et al. (1972) have evaluated, in patients with progressive osteoporosis, the use of fluoride combined with vitamin D and calcium supplementation. Treatment was monitored by examining bone biopsy specimens from the iliac crest at the commencement of the investigation and again at 12-17 months after treatment. The optimum dose of fluoride was about 45 mg of the sodium salt per day with 900 mg of supplemental calcium and 50 000 iu vitamin D twice weekly. After treatment bone formation was increased in all but one of the 11 patients on this regime and the group mean was significantly higher than before treatment. The newly formed bone was histologically normal but the effects of this therapy on the strength of bone must also be measured since it is believed that fluoride causes an increase in the crystallinity of bone structure and the bone may be mnore fragile than normal. Indeed in Jowsey's series 4 patients developed additional fractures of the vertebral bodies during treatment. Parathyroid hormone: The role of parathyroid hormone in osteoporosis is controversial. Berlyne et al. (1975) have reported a marked increase in the circulating levels of parathyroid hormone in the elderly with osteoporosis. It has been suggested that a reduction in the inhibitory effect of cestrogens on parathyroid-induced bone resorption is a factor in the development of osteoporosis after the menopause. However, Reeve et al. (1976) have produced evidence that human 1-34 parathyroid hormone given in low dosage increases bone formation and it may be of use in the treatment of osteoporosis. These effects occurred at dose levels which considerably increased calcium absorption from the diet in 3 of the 4 patients treated, but were insufficient to increase the, fasting levels of plasma calcium outside the normal range. The authors point out that the anabolic effects of parathyroid on bone have a long latency and once induced they may significantly outlast the period of administration of the hormone. It is proposed to reexamine the patients for further improvement after cessation of treatment. As in the case of fluoride, it has yet to be established whether this form of therapy will substantially increase bone mass and reduce the incidence of fractures.
Conclusion
There are -several promising new approaches to the treatment of osteoporosis. The effective management of osteoporosis, however, is handicapped by a number of problems: the difficulty in ascertainment of those people most likely to sustain fractures on account of accelerated bone loss, possibly associated with greatly diminished cestrogenic activity following the menopause; the lack of longitudinal studies which might establish the relationship between the development of clinical osteoporosis in old age on the one hand and the rate of bone loss and the skeletal status at maturity on the other; and by the inadequacy of present methods for making serial measurements of mineral content especially in those skeletal sites containing trabecular bone. Although aestrogens have been shown to be powerful inhibitors of bone resorption, and fluoride and parathyroid hormone may increase bone formation, the search must continue for other potent osteotrophic agents. It is of fundamental importance to establish that these potentially useful regimes confer benefit on the patients by a reduction in the fracture rate in later life.
